Air travel results in a lot of planet-warming emissions, but it's also sometimes necessary. That's a quandary for people who may be concerned about their personal contribution to the problem of ...

FALL RIVER — Who would have thought a positive trick play can change the entire complexity of a football game? Well it did for the Durfee football team on Friday night against non-league foe Taunton ...

The 2025 AFL season is complete. And with the premiership winner confirmed, all 18 clubs will officially turn their attention to the exchange period. Speaking on Fox Footy on Grand Final day, Herald ...

Today, Masahiro Sakurai hosted a 45-minute Nintendo Direct solely dedicated to his latest project, Kirby Air Riders. And it was a somewhat unusual Direct! Delivered in Sakurai's iconic style that he's ...

Schneider Electric, the global leader in energy management and automation and a recognised sustainability leader, has launched its flagship MasterPacT MTZ Active circuit breaker in West Africa, ...

The 19th Airlift Wing at Little Rock Air Force Base deactivated the 19th Operations Group and 19th Maintenance Group Thursday as part of an organizational restructuring effort. A 9 a.m. ceremony ...

High dose rezpegaldesleukin achieved statistical significance on multiple patient-reported outcome assessments at completion of 16-week induction period Interim data presented for patients who ...

Air India AI171 plane crash: A senior US attorney representing families of victims of the Air India flight AI171 tragedy has filed a Freedom of Information Act (FOIA) request in the United States, ...

SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it will present results from the ongoing REZOLVE-AD Phase 2b study at the 2025 European Academy of ...